المؤلفون: Coles, Alasdair J, Jones, Joanne L, Vermersch, Patrick, Traboulsee, Anthony, Bass, Ann D, Boster, Aaron, Chan, Andrew, Comi, Giancarlo, Fernández, Óscar, Giovannoni, Gavin, Kubala Havrdova, Eva, LaGanke, Christopher, Montalban, Xavier, Oreja-Guevara, Celia, Piehl, Fredrik, Wiendl, Heinz, Ziemssen, Tjalf

المصدر: Coles, Alasdair J; Jones, Joanne L; Vermersch, Patrick; Traboulsee, Anthony; Bass, Ann D; Boster, Aaron; Chan, Andrew; Comi, Giancarlo; Fernández, Óscar; Giovannoni, Gavin; Kubala Havrdova, Eva; LaGanke, Christopher; Montalban, Xavier; Oreja-Guevara, Celia; Piehl, Fredrik; Wiendl, Heinz; Ziemssen, Tjalf (2022). Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data. Multiple sclerosis journal, 28(5), pp. 842-846. Sage 10.1177/13524585211061335

مصطلحات موضوعية: 610 Medicine & health

وصف الملف: application/pdf

Relation: https://boris.unibe.ch/163565/

الاتاحة: https://boris.unibe.ch/163565/1/Coles__2021__Autoimmunity_and_long-term_safety_alemtuzumab.pdf
https://boris.unibe.ch/163565/

المؤلفون: Coles, Alasdair J., Jones, Joanne L., Vermersch, Patrick, Traboulsee, Anthony, Bass, Ann D., Boster, Aaron, Chan, Andrew, Comi, Giancarlo, Fernández, Óscar, Giovannoni, Gavin, Kubala Havrdova, Eva, LaGanke, Christopher, Montalban, Xavier, Oreja-Guevara, Celia, Piehl, Fredrik, Wiendl, Heinz, Ziemssen, Tjalf, Universitat Autònoma de Barcelona

مصطلحات موضوعية: Alemtuzumab, Autoimmunity, Multiple sclerosis, Post-marketing, Product surveillance, Risk assessment, Treatment outcome

وصف الملف: application/pdf

Relation: Multiple sclerosis; Vol. 28 Núm. 5 (2022), p. 842-846; https://ddd.uab.cat/record/275789; urn:10.1177/13524585211061335; urn:oai:ddd.uab.cat:275789; urn:pure_id:319790651; urn:scopus_id:85121289744; urn:pmid:34882037; urn:pmcid:PMC8978465; urn:articleid:14770970v28n5p842; urn:oai:pubmedcentral.nih.gov:8978465

الاتاحة: https://ddd.uab.cat/record/275789

المؤلفون: Jones, Joanne, Vermersch, Patrick, Bass, Ann D, Boster, Aaron, Montalban Gairín, Xavier, Coles, Alasdair, Traboulsee, Anthony

المساهمون: Institut Català de la Salut, Coles AJ, Jones JL Department of Clinical Neuroscience, School of Medicine, University of Cambridge, Cambridge, UK. Vermersch P Univ. Lille, INSERM UMR-S1172—Lille Neuroscience et Cognition, CHU Lille, FHU Precise, Lille, France. Traboulsee A The University of British Columbia, Vancouver, BC, Canada. Bass AD Neurology Center of San Antonio, San Antonio, TX, USA. Boster A Boster MS Center, Columbus, OH, USA. Montalban X Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Esclerosi múltiple - Tractament, Avaluació de resultats (Assistència sanitària), Autoimmunitat, DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis, Other subheadings::Other subheadings::Other subheadings::/drug therapy, PHENOMENA AND PROCESSES::Immune System Phenomena::Immunity::Autoimmunity, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, FENÓMENOS Y PROCESOS::fenómenos del sistema inmunitario::inmunidad::autoinmunidad, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento

وصف الملف: application/pdf

Relation: Multiple Sclerosis Journal;28(5); https://doi.org/10.1177/13524585211061335; Coles AJ, Jones JL, Vermersch P, Traboulsee A, Bass AD, Boster A, et al. Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data. Mult Scler J. 2022 Apr 1;28(5):842–846.; https://hdl.handle.net/11351/7650; 000729548200001

الاتاحة: https://hdl.handle.net/11351/7650
https://doi.org/10.1177/13524585211061335

المؤلفون: Bass, Ann D, Arroyo, Rafael, Boster, Aaron L, Boyko, Alexey N, Eichau, Sara, Ionete, Carolina, Limmroth, Volker, Navas, Carlos, Pelletier, Daniel, Pozzilli, Carlo, Ravenscroft, Jennifer, Sousa, Livia, Tintoré, Mar, Uitdehaag, Bernard M J, Baker, Darren P, Daizadeh, Nadia, Choudhry, Zia, Rog, David

المساهمون: Bass, Ann D, Arroyo, Rafael, Boster, Aaron L, Boyko, Alexey N, Eichau, Sara, Ionete, Carolina, Limmroth, Volker, Navas, Carlo, Pelletier, Daniel, Pozzilli, Carlo, Ravenscroft, Jennifer, Sousa, Livia, Tintoré, Mar, Uitdehaag, Bernard M J, Baker, Darren P, Daizadeh, Nadia, Choudhry, Zia, Rog, David

مصطلحات موضوعية: Age, Alemtuzumab, Efficacy, Long-term, Safety

Relation: info:eu-repo/semantics/altIdentifier/pmid/33476880; info:eu-repo/semantics/altIdentifier/wos/WOS:000641391200019; volume:49; firstpage:102717; journal:MULTIPLE SCLEROSIS AND RELATED DISORDERS; http://hdl.handle.net/11573/1519233; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85099636941

الاتاحة: http://hdl.handle.net/11573/1519233
https://doi.org/10.1016/j.msard.2020.102717

المؤلفون: VAN WIJMEERSCH, Bart, Singer, Barry A., Boster, Aaron, Broadley, Simon, Fernandez, Oscar, Freedman, Mark S., Izquierdo, Guillermo, Lycke, Jan, Pozzilli, Carlo, Sharrack, Basil, Steingo, Brian, Wiendl, Heinz, Wray, Sibyl, Ziemssen, Tjalf, Chung, Luke, Margolin, David H., Thangavelu, Karthinathan, Vermersch, Patrick

المساهمون: Ziemssen, Tjalf/0000-0001-8799-8202, VAN WIJMEERSCH, Bart, Singer, Barry A., Boster, Aaron, Broadley, Simon, Fernandez, Oscar, Freedman, Mark S., Izquierdo, Guillermo, Lycke, Jan, Pozzilli, Carlo, Sharrack, Basil, Steingo, Brian, Wiendl, Heinz, Wray, Sibyl, Ziemssen, Tjalf, Chung, Luke, Margolin, David H., Thangavelu, Karthinathan, Vermersch, Patrick

المصدر: Article

مصطلحات موضوعية: Alemtuzumab, disease-modifying therapy, relapsing-remitting multiple sclerosis (MS), efficacy, magnetic resonance imaging (MRI), disability

وصف الملف: application/pdf

Relation: MULTIPLE SCLEROSIS JOURNAL, 26 (13), p. 1719-1728; http://hdl.handle.net/1942/30883; 1728; 13; 1719; 26; WOS:000495335100001

الاتاحة: http://hdl.handle.net/1942/30883
https://doi.org/10.1177/1352458519881759

المؤلفون: Coles, Alasdair J, Arnold, Douglas L, Bass, Ann D, Boster, Aaron L, Compston, D Alastair S, Fernández, Óscar, Havrdová, Eva Kubala, Nakamura, Kunio, Traboulsee, Anthony, Ziemssen, Tjalf, Jacobs, Alan, Margolin, David H, Huang, Xiaobi, Daizadeh, Nadia, Chirieac, Madalina C, Selmaj, Krzysztof W

المصدر: essn: 1756-2864 ; nlmid: 101480242

مصطلحات موضوعية: CD52, MRI, alemtuzumab, brain volume, disability, disease activity, efficacy, extension, multiple sclerosis, relapse, safety

وصف الملف: application/pdf

Relation: https://www.repository.cam.ac.uk/handle/1810/324468

الاتاحة: https://www.repository.cam.ac.uk/handle/1810/324468
https://doi.org/10.17863/CAM.71920

المؤلفون: Coles, Alasdair J., Arnold, Douglas L., Bass, Ann D., Boster, Aaron L., Compston, D. Alastair S., Fernández, Óscar, Havrdová, Eva Kubala, Nakamura, Kunio, Traboulsee, Anthony, Ziemssen, Tjalf, Jacobs, Alan, Margolin, David H., Huang, Xiaobi, Daizadeh, Nadia, Chirieac, Madalina C., Selmaj, Krzysztof W.

المساهمون: Bayer HealthCare Pharmaceuticals, Sanofi

المصدر: Therapeutic Advances in Neurological Disorders ; volume 14 ; ISSN 1756-2864 1756-2864

الاتاحة: https://doi.org/10.1177/1756286420982134
https://journals.sagepub.com/doi/pdf/10.1177/1756286420982134
https://journals.sagepub.com/doi/full-xml/10.1177/1756286420982134

المؤلفون: Horáková, Dana, Boster, Aaron, Bertolotto, Antonio, Freedman, Mark S, Firmino*, Isabel, Cavalier, Steven J, Jacobs*, Alan K, Thangavelu*, Karthinathan, Daizadeh, Nadia, Poole*, Elizabeth M, Baker, Darren P, Margolin*, David H, Ziemssen, Tjalf

المساهمون: Bayer HealthCare Pharmaceuticals, Sanofi

المصدر: Multiple Sclerosis Journal - Experimental, Translational and Clinical ; volume 6, issue 4 ; ISSN 2055-2173 2055-2173

الاتاحة: https://doi.org/10.1177/2055217320972137
https://journals.sagepub.com/doi/pdf/10.1177/2055217320972137
https://journals.sagepub.com/doi/full-xml/10.1177/2055217320972137

المؤلفون: Vollmer, Timothy L., Cohen, Jeffrey A., Alvarez, Enrique, Nair, Kavita V., Boster, Aaron, Katz, Joshua, Pardo, Gabriel, Pei, Jinglan, Raut, Pranil, Merchant, Sharmin, MacLean, Elizabeth, Pradhan, Ashish, Moss, Brandon

المساهمون: Genentech

المصدر: Multiple Sclerosis and Related Disorders ; volume 46, page 102454 ; ISSN 2211-0348

الاتاحة: http://dx.doi.org/10.1016/j.msard.2020.102454
https://api.elsevier.com/content/article/PII:S2211034820305290?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2211034820305290?httpAccept=text/plain

المؤلفون: Comi, Giancarlo, Alroughani, Raed, Boster, Aaron L, Bass, Ann D, Berkovich, Regina, Fernández, Óscar, Kim, Ho Jin, Limmroth, Volker, Lycke, Jan, Macdonell, Richard Al, Sharrack, Basil, Singer, Barry A, Vermersch, Patrick, Wiendl, Heinz, Ziemssen, Tjalf, Jacobs, Alan, Daizadeh, Nadia, Rodriguez, Claudio E, Traboulsee, Anthony, CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators

مصطلحات موضوعية: Alemtuzumab, efficacy, multiple sclerosis, relapse, retreatment, safety, Humans, Interferon beta-1a, Relapsing-Remitting, Recurrence

وصف الملف: application/pdf

Relation: http://hdl.handle.net/10668/14739; PMC7720359; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720359/pdf

الاتاحة: http://hdl.handle.net/10668/14739
https://doi.org/10.1177/1352458519888610
https://journals.sagepub.com/doi/pdf/10.1177/1352458519888610
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720359/pdf

المؤلفون: Fox, Edward J., Buckle, Guy J., Singer, Barry, Singh, Vibhuti, Boster, Aaron

المصدر: Neurology Clinical Practice ; volume 9, issue 1, page 53-63 ; ISSN 2163-0402 2163-0933

الاتاحة: http://dx.doi.org/10.1212/cpj.0000000000000567
https://www.neurology.org/doi/pdfdirect/10.1212/CPJ.0000000000000567

المؤلفون: Barclay, Krista, Carruthers, Robert, Traboulsee, Anthony, Bass, Ann D., LaGanke, Christopher, Bertolotto, Antonio, Boster, Aaron, Celius, Elisabeth G., Seze, Jérôme de, Cruz, Dionisio Dela, Habek, Mario, Lee, Jong-Mi, Limmroth, Volker, Meuth, Sven G., Oreja-Guevara, Celia, Pagnotta, Patricia, Vos, Cindy, Ziemssen, Tjalf, Baker, Darren P., Wijmeersch, Bart Van

المساهمون: Sanofi

المصدر: Frontiers in Neurology ; volume 10 ; ISSN 1664-2295

الاتاحة: http://dx.doi.org/10.3389/fneur.2019.00253
https://www.frontiersin.org/article/10.3389/fneur.2019.00253/full

المؤلفون: Boster, Aaron, Nicholas, Jacqueline, Wu, Ning, Yeh, Wei-Shi, Fay, Monica, Edwards, Michael, Huang, Ming-Yi, Lee, Andrew

المساهمون: Biogen

المصدر: Neurology and Therapy ; volume 6, issue 1, page 91-102 ; ISSN 2193-8253 2193-6536

الاتاحة: http://dx.doi.org/10.1007/s40120-017-0064-x
http://link.springer.com/content/pdf/10.1007/s40120-017-0064-x.pdf

المؤلفون: Nicholas, Jacqueline, Boster, Aaron, Wu, Ning, Yeh, Wei-Shi, Fay, Monica, Kendter, Jon, Huang, Ming-Yi, Lee, Andrew

المساهمون: Biogen

المصدر: PharmacoEconomics - Open ; volume 2, issue 1, page 31-41 ; ISSN 2509-4262 2509-4254

الاتاحة: http://dx.doi.org/10.1007/s41669-017-0035-2
http://link.springer.com/article/10.1007/s41669-017-0035-2/fulltext.html
http://link.springer.com/content/pdf/10.1007/s41669-017-0035-2.pdf

المؤلفون: Pitt, David, Lo, Chih Hung, Gauthier, Susan A., Hickman, Richard A., Longbrake, Erin, Airas, Laura M., Mao-Draayer, Yang, Riley, Claire, De Jager, Philip Lawrence, Wesley, Sarah, Boster, Aaron, Topalli, Ilir, Bagnato, Francesca, Mansoor, Mohammad, Stuve, Olaf, Kister, Ilya, Pelletier, Daniel, Stathopoulos, Panos, Dutta, Ranjan, Lincoln, Matthew R.

المصدر: Neurology Neuroimmunology & Neuroinflammation ; volume 9, issue 6 ; ISSN 2332-7812

الاتاحة: http://dx.doi.org/10.1212/nxi.0000000000200025
https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200025

المؤلفون: Amjad, Faria, Boster, Aaron, Carod-Artal, Francisco Javier, Chinnapongse, Robert, Checketts, Daniel, Adjamian, Peyman, Steinerman, Joshua R.

المصدر: Neurology ; volume 98, issue 18_supplement ; ISSN 0028-3878 1526-632X

الاتاحة: http://dx.doi.org/10.1212/wnl.98.18_supplement.891

المؤلفون: Orack, Joshua C., Deleidi, Michela, Pitt, David, Mahajan, Kedar, Nicholas, Jacqueline A., Boster, Aaron L., Racke, Michael K., Comabella, Manuel, Watanabe, Fumihiro, Imitola, Jaime

المصدر: Stem Cells Translational Medicine ; volume 4, issue 3, page 252-260 ; ISSN 2157-6564 2157-6580

الاتاحة: http://dx.doi.org/10.5966/sctm.2014-0133
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.5966%2Fsctm.2014-0133
https://academic.oup.com/stcltm/article-pdf/4/3/252/41863892/stcltm_4_3_252.pdf

المؤلفون: Janssen, Alisha, Boster, Aaron, Lee, HyunKyu, Patterson, Beth, Prakash, Ruchika Shaurya

المصدر: Journal of Clinical and Experimental Neuropsychology ; volume 37, issue 3, page 285-302 ; ISSN 1380-3395 1744-411X

الاتاحة: http://dx.doi.org/10.1080/13803395.2015.1009366
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

المؤلفون: Boster, Aaron L, Ford, Corey C, Neudorfer, Orit, Gilgun-Sherki, Yossi

المصدر: Expert Review of Neurotherapeutics ; volume 15, issue 6, page 575-586 ; ISSN 1473-7175 1744-8360

الاتاحة: http://dx.doi.org/10.1586/14737175.2015.1040768
http://www.tandfonline.com/doi/pdf/10.1586/14737175.2015.1040768

المؤلفون: Coles, Alasdair, Jones, Joanna, Vermersch, Patrick, Traboulsee, Anthony, Bass, Ann D, Boster, Aaron, Chan, Andrew, Comi, Giancarlo, Fernández, Óscar, Giovannoni, Gavin, Kubala Havrdova, Eva, LaGanke, Christopher, Montalban, Xavier, Oreja-Guevara, Celia, Piehl, Fredrik, Wiendl, Heinz, Ziemssen, Tjalf

وصف الملف: application/pdf

Relation: https://www.repository.cam.ac.uk/handle/1810/330953

الاتاحة: https://www.repository.cam.ac.uk/handle/1810/330953
https://doi.org/10.17863/CAM.78397